<code id='499DF32DE4'></code><style id='499DF32DE4'></style>
    • <acronym id='499DF32DE4'></acronym>
      <center id='499DF32DE4'><center id='499DF32DE4'><tfoot id='499DF32DE4'></tfoot></center><abbr id='499DF32DE4'><dir id='499DF32DE4'><tfoot id='499DF32DE4'></tfoot><noframes id='499DF32DE4'>

    • <optgroup id='499DF32DE4'><strike id='499DF32DE4'><sup id='499DF32DE4'></sup></strike><code id='499DF32DE4'></code></optgroup>
        1. <b id='499DF32DE4'><label id='499DF32DE4'><select id='499DF32DE4'><dt id='499DF32DE4'><span id='499DF32DE4'></span></dt></select></label></b><u id='499DF32DE4'></u>
          <i id='499DF32DE4'><strike id='499DF32DE4'><tt id='499DF32DE4'><pre id='499DF32DE4'></pre></tt></strike></i>

          
          WSS
          Mayo Clinic, in Rochester, Minnesota on
          Photo by KEREM YUCEL/AFP via Getty Images

          SAN FRANCISCO — Mayo Clinic has signed Silicon Valley tech startup Cerebras as its first generative AI partner, the health system announced Monday.

          The health system — known for its cutting-edge research and willingness to partner with tech companies — will give Cerebras millions of dollars to help build technology tools based on Mayo’s trove of de-identified patient data, leaders announced at the J.P. Morgan Healthcare Conference. Mayo and Cerebras did not disclose the dollar amount, but Cerebras said it was a multimillion, multi-year contract.

          advertisement

          With roughly 380 employees, Cerebras builds and sells supercomputers specifically designed for AI applications across several industries — pitting the upstart in direct competition with the market leader Nvidia Corp. Life sciences giants including GSK have used its technology for drug discovery, and it has partnered with a health network in United Arab Emirates, but this is Cerebras’ first AI contract with a U.S. health system. The deal gives Mayo access to Cerebras’ supercomputers as well as a Cerebras team to help develop health-tuned models; Mayo will then own whatever they build.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          Leave your comment

          Please enter your name
          Please enter your comment

          comprehensive